Navigating Clinical Likelihood and Cardiovascular Risk over a Lifetime Course of Coronary Artery Disease [0.03%]
冠心病终身发病风险和心血管事件风险的变迁规律研究
Simon Winther,Laust D Rasmussen,Christiaan J M Vrints
Simon Winther
Longer-Term Efficacy and Safety of Zodasiran in Patients with Mixed Hyperlipidaemia [0.03%]
用于混合型高脂血症患者的Zodasiran的长期疗效和安全性
Robert S Rosenson,Daniel Gaudet,Christie M Ballantyne et al.
Robert S Rosenson et al.
Background: Mixed hyperlipidaemia, characterized by elevated cholesterol and triglyceride levels, is associated with increased risk of atherosclerotic cardiovascular disease (ASCVD). Angiopoietin-like protein 3 (ANGPTL3) ...
Early life and adulthood risk factors for middle age P-wave prolongation and left atrial enlargement [0.03%]
早年和成年期的风险因素与中年P波延长及左心房扩大之间的关系
Tiia Istolahti,Leo-Pekka Lyytikäinen,Heini Huhtala et al.
Tiia Istolahti et al.
Aims: P-wave prolongation and left atrial (LA) enlargement are markers of atrial cardiomyopathy and increase the risk for atrial fibrillation, stroke, and mortality. We investigated whether the cumulative burden of cardio...
Baseline Anemia and Short Dual Antiplatelet Therapy in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention [0.03%]
高出血风险患者行经皮冠状动脉介入治疗的基线贫血和短期双重抗血小板治疗
Francesca Maria Di Muro,Samantha Sartori,Dominick J Angiolillo et al.
Francesca Maria Di Muro et al.
Aims: In patients at high bleeding risk (HBR) undergoing percutaneous coronary intervention (PCI), abbreviated dual antiplatelet therapy (DAPT) has been shown to reduce bleeding without increasing ischemic risk. However, ...
A novel method to classify exercise response in patients with cardiac amyloidosis - The RoMa classification [0.03%]
心脏淀粉样变患者运动反应的新型分类方法-Roma标准
Antonio Kösters,Nikita Ermolaev,Elisabetta Salvioni et al.
Antonio Kösters et al.
Aims: To evaluate the applicability of the RoMa classification in patients with transthyretin cardiac amyloidosis (ATTR-CM) and to assess its association with functional capacity and key cardiopulmonary exercise testing (...
Factors associated with enhanced LDL cholesterol lowering with bempedoic acid among statin-intolerant patients from CLEAR Outcomes [0.03%]
来自CLEAR Outcomes研究的他汀不耐受患者使用bempedoic酸治疗后LDL胆固醇降低增强的相关因素
Christie M Ballantyne,Sahar Naderi,Pam R Taub et al.
Christie M Ballantyne et al.
Beta-blocker therapy after acute coronary syndrome in patients without heart failure or reduced ejection fraction: A target-trial emulation study [0.03%]
急性冠脉综合征患者出院后β受体阻滞剂治疗的效应：目标 trials 仿真实验研究
V De Sio,F Gragnano,A Cesaro et al.
V De Sio et al.
Aims: The benefits of β-blockers in patients with acute coronary syndromes (ACS) without chronic heart failure (HF) or left ventricular ejection fraction (LVEF) < 40% remain uncertain. We evaluated the association betwee...
Nutritional Interventions in Cardiac Rehabilitation: Current Evidence, Evidence Gaps, and Future Directions-A Scoping Review [0.03%]
心脏康复中的营养干预：现有证据、证据缺口及未来方向——系统综述
Aya Elalfy,Mahmoud Abdelnabi,Ahmed Elmorsy Mohamed et al.
Aya Elalfy et al.
Background and aims: Nutritional counseling is a core component of cardiac rehabilitation (CR), yet the evidence base for specific dietary interventions within CR remains fragmented. This scoping review aimed to map the r...
Non-HDL-cholesterol and residual cardiovascular risk in statin-treated primary-prevention patients [0.03%]
他汀治疗的初级预防患者中的非HDL胆固醇与剩余心血管风险
Jaechan Park,Ju Hyun Kang,Seulggie Choi et al.
Jaechan Park et al.
Multidisciplinary cardiac rehabilitation-an indispensable therapeutic intervention when starting a GLP-1 receptor agonist therapy? [0.03%]
多学科心脏康复？在开始GLP-1受体激动剂治疗时必不可少的疗法？
Bernhard Rauch,Elena Tessitore
Bernhard Rauch